The effect of food on the pharmacokinetics of multiple-dose terbinafine in young and elderly healthy subjects

Biopharmaceutics and Drug Disposition

Volumn 18, Issue 2, 1997, Pages 127-138

  Nedelman, Jerry ^a   Cramer, Jeffrey A ^a   Robbins, Bruce ^a   Gibiansky, Ekaterina ^a   Chang, Cheng Tao ^a   Gareffa, Stephen ^a   Cohen, Albert ^b   Meligeni, John ^a  

^a Sandoz Pharma Ltd   (Switzerland)

^b Peninsular Testing Corporation   (United States)

Author keywords

compartmental modeling; Lamisil ; onychomycosis; pharmacokinetics

Indexed keywords

TERBINAFINE;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; FOOD DRUG INTERACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; THEORETICAL STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; FOOD; HUMANS; MIDDLE AGED; MODELS, BIOLOGICAL; MODELS, STATISTICAL; NAPHTHALENES; REFERENCE VALUES;

EID: 0031002048     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199703)18:2<127::AID-BDD6>3.0.CO;2-8     Document Type: Article

References (10)

1. J. Birnbaum, Pharmacology of allylamines. J. Am. Acad. Dermatol., 23, 782-785 (1990).
2. V. V. Villars and T. C. Jones, Special features of the clinical use of oral terbinafine in the treatment of fungal diseases. Br. J. Dermatol., 126, Suppl. 39, 61-69 (1992).
3. Sandoz Pharmaceuticals, unpublished internal reports.
4. J. R. Nedelman, E. Gibiansky, B. A. Robbins, J. A. Cramer, J. F. Riefler, T. Lin and J. A. Meligeni, Multiple dose pharmacokinetics and pharmacodynamics of terbinafine. J. Clin. Pharmacol., 36, 452-461 (1996).
5. A. C. Atkinson, Plot, Transformations, and Regression, Clarendon, Oxford, 1985, pp. 85-87.
6. J. C. Jensen, Clinical pharmacokinetics of terbinafine (Lamisil). Clin. Exp. Dermatol., 14, 110-113 (1989).
7. J. C. Jensen, Pharmacokinetics of Lamisil in humans. J. Dermatol. Treatment 1, Suppl. 2, 15-18 (1990).
8. J. M. Kovarik, S. Kirkesseli, H. Humbert, P. Grass and K. Kutz, Dose proportional pharmacokinetics of terbinafine and its N-demethylated metabolite in healthy volunteers. Br. J. Dermatol., 126, Suppl. 39, 8-13 (1992).
9. SAS Institute, Cary, NC.
10. G. A. F. Seber and C. J. Wild, Nonlinear Regression, Wiley, New York, 1989, p. 198.